OR YAT SUN,OWENS CHRISTOPHER M,BRASHER BRADLEY B,QIU YAO LING,JIANG LIJUAN
申请号：
IN8200/DELNP/2012
公开号：
IN2012DN08200A
申请日:
2012.09.19
申请国别(地区):
IN
年份:
2014
代理人:
摘要：
The present invention relates to pharmaceutical agents administered to a subject either in combination or in series for the treatment of a flaviviridae viral infection for example hepatitis C virus (HCV) wherein treatment comprises administering a compound effective to inhibit the function of the HCV NS5A protein and an additional compound or combinations of compounds having anti HCV activity.
